➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
Mallinckrodt
Medtronic
Colorcon
Moodys

Last Updated: July 9, 2020

DrugPatentWatch Database Preview

INTRALIPID 20% Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Which patents cover Intralipid 20%, and when can generic versions of Intralipid 20% launch?

Intralipid 20% is a drug marketed by Fresenius and is included in two NDAs.

The generic ingredient in INTRALIPID 20% is soybean oil. There are thirteen drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the soybean oil profile page.

Summary for INTRALIPID 20%
Drug patent expirations by year for INTRALIPID 20%
Recent Clinical Trials for INTRALIPID 20%

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Yale UniversityPhase 1/Phase 2
Amani Hassan Abdel-WahabPhase 2/Phase 3
Tanta UniversityPhase 4

See all INTRALIPID 20% clinical trials

Pharmacology for INTRALIPID 20%
Drug ClassLipid Emulsion

US Patents and Regulatory Information for INTRALIPID 20%

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius INTRALIPID 20% soybean oil INJECTABLE;INJECTION 018449-001 Approved Prior to Jan 1, 1982 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
Fresenius INTRALIPID 20% soybean oil INJECTABLE;INJECTION 020248-001 Aug 7, 1996 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
Mallinckrodt
Medtronic
Colorcon
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.